This section is intended for patients prescribed ADCETRIS in Great Britain. If you are a member of the public in Great Britain click here. If you are a GB healthcare professional click here.

Contact Us

How can we help you?

If you are a member of the public requiring advice or information on your medical condition or treatment please contact your doctor or visit the NHS website in the first instance.

To contact the medical information department at Takeda UK Ltd, please use the form below.

Fields marked with an * are mandatory.

These details will only be used to help answer your question, and will never be used for promotional purposes.

Please read our Website Privacy Policy before sending us any personal data via email.

Head office

1 Kingdom Street

London

W2 6BD

United Kingdom

Email: medinfoemea@takeda.com

C-ANPROM/UK/ADCE/0037 - December 2021

ADCETRIS (brentuximab vedotin) is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects whilst taking ADCETRIS, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the patient information leaflet.


You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.